Skip to content

Decoding PEA: What are the side effects of taking PEA?

4 min read

A single acronym, PEA, can refer to two completely different compounds, phenylethylamine and palmitoylethanolamide, with vastly different safety profiles. Understanding which substance you are taking is critical, as what are the side effects of taking PEA depends entirely on the specific molecule in question.

Quick Summary

The term PEA can refer to either phenylethylamine, which acts as a stimulant and has amphetamine-like side effects, or palmitoylethanolamide, a fatty acid amide with mild, rare side effects. The potential risks vary significantly based on which compound is being used.

Key Points

  • Two Different Molecules: The acronym PEA can refer to either phenylethylamine, a stimulant with amphetamine-like effects, or palmitoylethanolamide, an endogenous fatty acid with anti-inflammatory properties.

  • Phenylethylamine Risks: Phenylethylamine can cause serious side effects, including rapid heart rate, anxiety, and dangerous interactions with MAOI antidepressants.

  • Palmitoylethanolamide Safety: Palmitoylethanolamide is generally well-tolerated, with very rare and mild side effects like nausea or stomach discomfort.

  • Medication Interactions: Phenylethylamine should not be taken with MAOIs or other serotonergic drugs due to the risk of serotonin syndrome. Palmitoylethanolamide has no known problematic drug interactions.

  • Consult a Doctor: Always consult a healthcare provider to determine which type of PEA is in a supplement and to ensure it is safe for your individual health status, especially if you have pre-existing conditions or take other medications.

  • Distinguish the Products: Check supplement labels carefully. Phenylethylamine is often sold as PEA HCl, while palmitoylethanolamide is often sold specifically for pain or inflammation.

In This Article

The acronym PEA is a source of considerable confusion in the world of supplements and pharmacology, as it commonly represents two distinct molecules: phenylethylamine (PEA) and palmitoylethanolamide (PEA). Given their different chemical structures and functions, their side effects and safety concerns are completely different. This guide will clarify the risks associated with each substance.

Side Effects of Phenylethylamine (PEA)

Phenylethylamine, sometimes labeled as PEA HCl, is a naturally occurring trace amine found in the human brain, which also acts as a stimulant and is structurally similar to amphetamines. Due to its stimulating properties, taking this form of PEA can cause a range of side effects, especially at higher doses. WebMD classifies it as "possibly unsafe" when taken orally.

Minor and Moderate Side Effects

These adverse effects are more common, particularly when starting supplementation or when doses are too high.

  • Rapid Heart Rate: Phenylethylamine can increase heart rate, which can lead to a feeling of racing or pounding in the chest.
  • Anxiety and Agitation: Its stimulant nature can cause nervousness, jitters, and a feeling of agitation.
  • Headaches: Mild to severe headaches have been reported by some users.
  • Gastrointestinal Distress: This can include nausea, upset stomach, or constipation.
  • Dizziness and Confusion: Some individuals may experience confusion or lightheadedness, particularly with higher doses.

Severe and Potentially Dangerous Side Effects

These risks highlight why caution is necessary with phenylethylamine, especially for certain individuals.

  • Serotonin Syndrome: Taking phenylethylamine alongside serotonergic drugs, such as certain antidepressants (MAOIs), can cause dangerously high serotonin levels. This can lead to serious side effects, including severe headaches, heart problems, shivering, and anxiety.
  • Exacerbation of Mental Illness: This form of PEA can worsen symptoms in people with conditions like bipolar disorder (by triggering mania) or schizophrenia (by worsening hallucinations).
  • Cardiovascular Risks: Given its amphetamine-like effects, there is a risk of severe cardiovascular complications, especially when combined with other stimulants.
  • Positive Drug Test: In high doses, phenylethylamine may cause a false positive test result for amphetamines, another important consideration.

Side Effects of Palmitoylethanolamide (PEA)

In contrast to phenylethylamine, palmitoylethanolamide is a fatty acid amide that the body naturally produces. It is widely studied for its anti-inflammatory and analgesic properties and is generally considered safe and well-tolerated in clinical trials. Side effects are rare and typically mild.

Rare and Mild Side Effects

  • Nausea: A small number of users have reported experiencing mild nausea.
  • Stomach Discomfort: Some cases of general stomach or gastrointestinal discomfort have been reported.
  • Drowsiness: Very rarely, some individuals may experience drowsiness.
  • No Significant Interactions: No serious drug-drug interactions have been reported with palmitoylethanolamide.

Comparison of Phenylethylamine vs. Palmitoylethanolamide Side Effects

To avoid confusion, here is a direct comparison of the two substances.

Feature Phenylethylamine (PEA) Palmitoylethanolamide (PEA)
Classification Stimulant, trace amine Endogenous fatty acid amide
Primary Use Nootropic, mood enhancement Anti-inflammatory, pain relief
General Safety Considered possibly unsafe, especially at high doses Generally well-tolerated and safe
Common Side Effects Rapid heart rate, anxiety, agitation, headache Rare and mild; nausea, stomach discomfort
Severe Risks Serotonin syndrome (with MAOIs), worsening of mental illness, cardiovascular issues None reported in clinical trials
Drug Interactions Significant interactions with MAOIs and other serotonergic drugs No known problematic drug-drug interactions

Who Should Avoid Each Type of PEA?

Knowing who should avoid these substances is critical for safe use.

Precautions for Phenylethylamine

  • Anyone on MAOIs or Serotonergic Drugs: This is a major contraindication due to the risk of serotonin syndrome.
  • Individuals with Mental Health Conditions: People with bipolar disorder or schizophrenia should avoid it due to the risk of exacerbating symptoms.
  • Pregnant or Breastfeeding Individuals: Due to a lack of reliable safety data, this population should avoid it.
  • People Undergoing Surgery: Phenylethylamine can affect the central nervous system and should be discontinued at least two weeks prior to any surgery.

Precautions for Palmitoylethanolamide

  • Long-Term Use: While generally considered safe for shorter durations, information on use longer than three to six months is less robust. A doctor's guidance for prolonged use is advisable.
  • Pregnant or Breastfeeding Individuals: Similar to other supplements, there is a lack of reliable safety information.

Conclusion

While the name PEA might be misleading, the safety profiles of phenylethylamine and palmitoylethanolamide could not be more different. Phenylethylamine poses significant risks, particularly related to its stimulant effects and serious interactions with other medications. In contrast, palmitoylethanolamide is generally considered a safe supplement with rare, mild side effects. It is essential for consumers to carefully check supplement labels to identify which PEA they are purchasing and to consult a healthcare provider, especially if taking other medications or managing an underlying health condition. For reliable information and patient-specific advice, consult resources like WebMD or your physician before beginning any new supplement regimen.

This article is for informational purposes only and does not constitute medical advice. Consult with a healthcare professional before starting any new supplement.

Frequently Asked Questions

You must check the supplement label for the full name. Phenylethylamine may be listed as 'PEA HCl' or just 'Phenylethylamine'. Palmitoylethanolamide supplements will typically be labeled with the full name, sometimes with a proprietary name attached, and are often marketed for pain relief or inflammation.

Combining phenylethylamine with an MAOI (a class of antidepressants) can lead to a serious and potentially fatal condition called serotonin syndrome. This can cause a severe increase in serotonin, leading to heart problems, headaches, shivering, and anxiety.

Clinical trials have shown that palmitoylethanolamide is safe and well-tolerated for up to 6 months of use for chronic pain management, with no serious adverse effects reported. However, data on use beyond this period is limited.

Yes, particularly at high doses, phenylethylamine's structural similarity to amphetamines can cause a false positive result for amphetamines or methamphetamines on a drug test.

For both phenylethylamine and palmitoylethanolamide, there is not enough reliable information to determine safety during pregnancy or breastfeeding. It is best to avoid use in this population.

Individuals taking MAOI antidepressants or other serotonergic drugs should avoid it. It is also contraindicated for those with bipolar disorder or schizophrenia, and people preparing for surgery.

The most common side effects are rare and mild, including slight nausea, stomach discomfort, or headaches.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.